Cargando…
Multicentre, double-blind, crossover trial to identify the Optimal Pathway for TreatIng neurOpathic paiN in Diabetes Mellitus (OPTION-DM): study protocol for a randomised controlled trial
BACKGROUND: The number of people with diabetes is growing rapidly. Diabetes can cause nerve damage leading to severe pain in the feet, legs and hands, which is known as diabetic peripheral neuropathic pain (DPNP). In the UK, the National Institute for Health and Care Excellence (NICE) recommends ami...
Autores principales: | Selvarajah, Dinesh, Petrie, Jennifer, White, David, Julious, Steven, Bortolami, Oscar, Cooper, Cindy, Bradburn, Mike, Loban, Amanda, Bowler, Helen, Swaby, Lizzie, Sutherland, Katie, Tesfaye, Solomon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196556/ https://www.ncbi.nlm.nih.gov/pubmed/30348206 http://dx.doi.org/10.1186/s13063-018-2959-y |
Ejemplares similares
-
Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial
por: Tesfaye, Solomon, et al.
Publicado: (2022) -
Design, planning and implementation lessons learnt from a surgical multi-centre randomised controlled trial
por: Biggs, Katie, et al.
Publicado: (2019) -
An evaluation of risk-based monitoring in pragmatic trials in UK Clinical Trials Units
por: Beever, Daniel, et al.
Publicado: (2019) -
Third workshop on Bayesian Deep Learning (NeurIPS 2018)
Publicado: (2018) -
36th Conference on Neural Information Processing Systems (NeurIPS 2022)
Publicado: (2022)